Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

NCT03356639 ·Status: COMPLETED ·Phase: PHASE1

Quality of Life in Schizophrenic Patients

NCT00597168 ·Status: COMPLETED

A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

NCT01959659 ·Status: COMPLETED

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

NCT03809325 ·Status: COMPLETED

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis

NCT01765829 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

NCT03164876 ·Status: COMPLETED ·Phase: PHASE1

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

NCT02220504 ·Status: COMPLETED ·Phase: NA

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

NCT02409823 ·Status: COMPLETED

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

NCT01052103 ·Status: COMPLETED ·Phase: PHASE2

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

NCT02534363 ·Status: COMPLETED ·Phase: PHASE4

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

NCT00669903 ·Status: TERMINATED ·Phase: PHASE2

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

NCT04895488 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Early Detection and Intervention for Women At-risk of Psychosis

NCT03751865 ·Status: UNKNOWN ·Phase: NA

Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

NCT01769014 ·Status: UNKNOWN

Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

NCT03481465 ·Status: UNKNOWN

Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders

NCT04783285 ·Status: COMPLETED ·Phase: NA

Hormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset Psychosis

NCT04418570 ·Status: COMPLETED ·Phase: NA

Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention

NCT05115604 ·Status: COMPLETED ·Phase: NA

A Clinical Trial on the Antipsychotic Properties of Cannabidiol

NCT00309413 ·Status: COMPLETED ·Phase: PHASE2

Subjective Well Being of Schizophrenic Patients in Greece

NCT00857064 ·Status: COMPLETED

Trial of Cognitive Behavioral Therapy for Schizophrenia

NCT00300651 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

NCT00330226 ·Status: UNKNOWN

Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia

NCT03509597 ·Status: UNKNOWN ·Phase: NA

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

NCT00528905 ·Status: COMPLETED ·Phase: PHASE2

Skills Group for Youth at Clinical High-Risk for Psychosis

NCT05398120 ·Status: RECRUITING ·Phase: NA